Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04248205 · ClinicalTrials.gov registry record · Phase 4
Ketamine for Post-operative Analgesia in Hemorrhoidectomy
A Phase 4 study of Hemorrhoids, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04248205 is a Phase 4 study of Hemorrhoids that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 100 participants, above the 58-participant average among 3 other Hemorrhoids trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04248205, a Phase 4 study of Hemorrhoids, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, randomized study of ketamine versus no ketamine in approximately 100 patients undergoing hemorrhoidectomy for Grade III or IV hemorrhoids. The participants will be blinded to which treatment arm they are assigned, because participants will be under anesthesia when the ketamine is administered. The investigators will know whether the participant receives ketamine or not.
Conditions Studied
Interventions
- DRUG Ketamine
Study Locations (1)
Oklahoma
- University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2025-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04248205
The ClinicalTrials.gov registry entry for NCT04248205 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 58-participant average among 3 other Hemorrhoids trials with a reported enrollment target (72% higher). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hemorrhoids appearing as the primary indexed condition, and to 1 intervention - of which Ketamine is the first listed.
NCT04248205 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT04248205 about?
NCT04248205 is a clinical study titled "Ketamine for Post-operative Analgesia in Hemorrhoidectomy". This is a prospective, randomized study of ketamine versus no ketamine in approximately 100 patients undergoing hemorrhoidectomy for Grade III or IV hemorrhoids. The participants will be blinded to which treatment arm they are assigned, because participants will be under anesthesia when the ketamine...
What is the current status of trial NCT04248205?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2020-06-15. Estimated completion is 2025-07.
What conditions does trial NCT04248205 study?
This clinical trial studies the following conditions: Hemorrhoids.
What interventions are being tested in trial NCT04248205?
The interventions under investigation include: Ketamine (DRUG).
Who is sponsoring clinical trial NCT04248205?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04248205 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemorrhoids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.